Y.D. More Investments’s Bristol-Myers Squibb BMY Stock Holding History

Y.D. More Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112K	Sell	1,846 -617	-25%	-$36K	﹤0.01%	244
2025 Q4	$133K	Sell	2,463 -771	-24%	-$37.1K	0.01%	218
2025 Q3	$146K	Buy	+3,234	New	+$151K	0.01%	231
2025 Q1	–	Sell	-3,375	Closed	-$191K	–	469
2024 Q4	$191K	Buy	3,375 +40	+1%	+$2.23K	0.02%	194
2024 Q3	$173K	Buy	3,335 +1,308	+65%	+$61.4K	0.02%	202
2024 Q2	$84.2K	Buy	+2,027	New	+$90.7K	0.01%	268
2024 Q1	–	Sell	-49	Closed	-$2.51K	–	335
2023 Q4	$2.51K	Buy	+49	New	+$2.57K	﹤0.01%	340
2023 Q1	–	Sell	-40	Closed	-$2.88K	–	360
2022 Q4	$2.88K	Buy	+40	New	+$3.02K	﹤0.01%	386

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Y.D. More Investments's BMY Position: Q1 2026 in Review

Y.D. More Investments reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, selling an estimated $36K and leaving 1,846 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

Y.D. More Investments first reported a position in BMY in Q4 2022 and has held it in 8 quarters since. The position peaked at $191K in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Y.D. More Investments held 1,846 shares of Bristol-Myers Squibb worth $112K as of Q1 2026.
Y.D. More Investments sold 617 Bristol-Myers Squibb shares in Q1 2026, an estimated $36K.
Bristol-Myers Squibb made up ﹤0.01% of Y.D. More Investments's portfolio in Q1 2026, its #244 holding.
Y.D. More Investments first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 8 quarters since.
Y.D. More Investments's Bristol-Myers Squibb position peaked at $191K in Q4 2024.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.